CAS No |
Product Name |
Molecular Formula |
1330266-05-1
|
Sulfadoxine-d4;4-Amino-N-(5,6-dimethoxy-4-pyrimidinyl)(2H4)benzenesulfonamide
|
C12H10D4N4O4S
|
1330750-23-6
|
5-Bromo-4-fluoro-2-nitrobenzoic acid
|
C7H3BrFNO4
|
1330750-27-0
|
6-Amino-2,3-difluorophenol hydrochloride (1:1)
|
C6H5F2NO.HCl
|
1330750-61-2
|
3-Thietanemethanamine
|
C4H9NS
|
1330763-95-5
|
1-Boc-1,6-diazaspiro[3.3]heptane oxalate
|
|
1330765-47-3
|
tert-butyl cis-3a,6a-difluoro-2,3,4,6-tetrahydro-1H-pyrrolo(3,4-c)pyrrole-5-carboxylate
|
C11H18F2N2O2
|
1331637-48-9
|
N,N'-((Methylenebis(sulfanediyl))bis(ethane-2,1-diyl))bis(N-methyl-2-nitroethene-1,1-diamine)
|
C11H22N6O4S2
|
1331756-62-7
|
4'-(4,6-Bis(4'-carboxy(1,1'-biphenyl)-4-yl)-1,3,5-triazin-2-yl)-(1,1'-biphenyl)-4-carboxylic acid
|
C42H27N3O6
|
1331782-27-4
|
Tetrahydro-4-((4-(((4-(((3R)-tetrahydro-3-furanyl)oxy)-1,2-benzisoxazol-3-yl)oxy)methyl)-1-piperidinyl)methyl)-2H-pyran-4-ol
|
C23H32N2O6
|
1332075-63-4
|
2-(1-((2-(5-Fluoro-1H-indol-4-yl)-4-(morpholin-4-yl)pyrido(3,2-d)pyrimidin-6-yl)methyl)piperidin-4-yl)propan-2-ol
|
C28H33FN6O2
|
1332524-01-2
|
N-(3-Fluoro-4-((methylamino)carbonyl)phenyl)-2-methylalanine methyl ester
|
C13H17FN2O3
|
1332713-64-0
|
5-(4'-((2-Butyl-4-chloro-5-((1-methylethoxy)methyl)-1H-imidazol-1-yl)methyl)(1,1'-biphenyl)-2-yl)-2H-tetrazole
|
C25H29ClN6O
|
1332724-03-4
|
Citalopram EP Impurity B Oxalate;3-Hydroxy Citalopram Oxalate
|
C22H23FN2O6
|
1332855-89-6
|
Methyl 3-(benzyloxy)-4-oxo-4H-pyran-2-carboxylate
|
C14H12O5
|
1332881-26-1
|
Sabizabulin;VERU-111; (2-(1H-indol-3-yl)-1H-imidazol-5-yl)-(3,4,5-trimethoxyphenyl)methanone
|
C21H19N3O4
|
1333002-37-1
|
1-Bromo-9-phenyl-9H-carbazole
|
C18H12BrN
|
1333151-73-7
|
(2Z)-3-(3-(3-Methoxy-5-(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-2-propenoic acid 1-methylethyl ester
|
C16H16F3N3O3
|
1333154-10-1
|
5-(3,5-Bis(trifluoromethyl)phenyl)-1H-1,2,4-triazole
|
C10H5F6N3
|
1333231-43-8
|
N-((1S)-1-((((1S)-1-(Hydroxymethyl)-2-(2-oxo-3-pyrrolidinyl)ethyl)amino)carbonyl)-3-methylbutyl)carbamic acid phenylmethyl ester
|
C21H31N3O5
|
1333317-99-9
|
Poly(((2,4,6-trimethylphenyl)imino)(1,1'-biphenyl)-4,4'-diyl);PTAA
|
(C21H19N)n
|
1333323-17-3
|
10-Deacetylyunnanxane;((1S,2S,3S,5S,8S,10S,14S)-2,5-diacetyloxy-10-hydroxy-8,12,15,15-tetramethyl-4-methylidene-14-tricyclo(9.3.1.03,8)pentadec-11-enyl) (2R,3S)-3-hydroxy-2-methylbutanoate
|
C29H44O8
|
1333377-65-3
|
3-(1H-Indazol-5-yl)-N-propylimidazo(1,2-b)pyridazin-6-amine;CHR 6494
|
C16H16N6
|
1333390-56-9
|
Regorafenib Urea Impurity;1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(2-fluoro-4-hydroxyphenyl)urea
|
C14H9ClF4N2O2
|
1333995-14-4
|
Aprepitant Impurity 5 HCl;(2S,3S)-2-((S)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine hydrochloride
|
C20H18F7NO2 .HCl
|
1333998-21-2
|
Des-1,2,4-triazol-3-one-5-methyl (2R,3R,2-(S))-Aprepitant Hydrochloride;(2R,3R)-2-{(1S)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy}-3-(4-fluorophenyl)morpholine hydrochloride (1:1)
|
C20H19ClF7NO2
|
1333998-27-8
|
Fosaprepitant Morpholine Hydrochloride;(2S,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine;hydrochloride
|
C20H19ClF7NO2
|
1334172-76-7
|
(3aS,4S,6aR)-N-(23-Amino-3,6,9,12,15,18,21-heptaoxatricos-1-yl)hexahydro-2-oxo-1H-thieno(3,4-d)imidazole-4-pentanamide
|
C26H50N4O9S
|
1334177-86-4
|
1-Maleimido-3-oxo-7,10,13,16,19,22,25,28-octaoxa-4-aza-hentriacontan-31-oic acid
|
C26H44N2O13
|
1334179-85-9
|
2-(4-((Bis((1-tert-butyl-1H-1,2,3-triazol-4-yl)methyl)amino)methyl)-1H-1,2,3-triazol-1-yl)acetic acid;BTTAA
|
C19H30N10O2
|
1334294-43-7
|
6-Chloro-4-(4-morpholinylmethyl)-2-pyridinamine
|
C10H14ClN3O
|
1334298-90-6
|
Itacitinib;INCB 039110; 1-(1-((3-Fluoro-2-(trifluoromethyl)-4-pyridinyl)carbonyl)-4-piperidinyl)-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-azetidineacetonitrile
|
C26H23F4N9O
|
1334302-63-4
|
Hexanedioic acid, compd. with 1-(1-((3-fluoro-2-(trifluoromethyl)-4-pyridinyl)carbonyl)-4-piperidinyl)-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-azetidineacetonitrile (1:1)
|
C26H23F4N9O.C6H10O4
|
1334493-07-0
|
4-(((4-Cyclohexylphenyl)methyl)(2-(methyl((2,3,4,5,6-pentafluorophenyl)sulfonyl)amino)acetyl)amino)-2-hydroxybenzoic acid;BP 1-102
|
C29H27F5N2O6S
|
1334497-06-1
|
Chloro(crotyl)(di-tert-butyl(4-dimethylaminophenyl)phosphine)palladium(II)
|
C20H35ClNPPd
|
1334499-86-3
|
5-Fluoro-3-iodo-1H-pyrrolo(2,3-b)pyridine-2-carboxylic acid ethyl ester
|
C10H8FIN2O2
|
1334499-90-9
|
5,7-Difluoro-3-iodo-1H-indole-2-carboxylic acid ethyl ester
|
C11H8F2INO2
|
1334509-86-2
|
N-((9H-Fluoren-9-ylmethoxy)carbonyl)-1-methyl-L-tryptophan
|
C27H24N2O4
|
1334513-02-8
|
N-((S)-(2,3,4,5,6-Pentafluorophenoxy)phenoxyphosphinyl)-L-alanine 1-methylethyl ester
|
C18H17F5NO5P
|
1334532-19-2
|
(R)-Propionyl Carnitine-d3 Chloride
|
C10H17D3ClNO4
|
1334532-24-9
|
Octanoyl L-Carnitine-d3 Chloride
|
C15H27D3ClNO4
|
1334532-25-0
|
Myristoyl-L-carnitine-d3 Hydrochloride
|
C21H39D3ClNO4
|
1334532-26-1
|
Palmitoyl-L-carnitine-d3 Hydrochloride
|
C23H43D3ClNO4
|
1334547-76-0
|
Chloro(2-{bis(3,5-bis(trifluoromethyl)phenyl)phosphino}-3,6-dimethoxy-2',4',6'-triisopropyl-1,1'-biphenyl)gold(I)
|
C39H37AuClF12O2P
|
1334719-95-7
|
6-Chloro-2-ethyl-N-((4-(4-(4-(trifluoromethoxy)phenyl)-1-piperidinyl)phenyl)methyl)imidazo(1,2-a)pyridine-3-carboxamide;IAP 6; Q 203
|
C29H28ClF3N4O2
|
1334782-79-4
|
2-(2-methylimidazo(2,1-b)(1,3)thiazol-6-yl)-1-(2-((1R)-5-(6-methylpyrimidin-4-yl)-2,3-dihydro-1H-inden-1-yl)-2,7-diazaspiro(3.5)nonan-7-yl)ethanone
|
C29H32N6OS
|
1334890-93-5
|
(1,10-Phenanthroline)(trifluoromethyl)(triphenylphosphine)copper(I)
|
C31H23CuF3N2P
|
1335054-04-0
|
Ethyl 6-bromo-4-chloronicotinate
|
C8H7BrClNO2
|
1335054-80-2
|
2-Bromo(1,2,4)triazolo(1,5-a)pyrimidine
|
C5H3BrN4
|
1335057-22-1
|
5-Bromo-6-chloro-3-nitro-2-pyridinamine
|
C5H3BrClN3O2
|
1335110-44-5
|
Rosuvastatin EP impurity H;5-(8-fluoro-2-(methyl(methylsulfonyl)amino)-4-propan-2-yl-5,6-dihydrobenzo(h)quinazolin-6-yl)-3,5-dihydroxypentanoate;methane
|
C23H31FN3O6S-
|